Further evidence of high level of persistence of pediatric bipolar-I disorder from childhood onto young adulthood: a five-year follow up
, , , , , y
10 jul 2018
Acerca de este artículo
Categoría del artículo: research-article
Publicado en línea: 10 jul 2018
Páginas: 40 - 51
DOI: https://doi.org/10.21307/sjcapp-2018-005
Palabras clave
© 2018 Janet Wozniak et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.

Figure 2.

Figure 3.

Figure 4.

Demographic characteristics of subjects with syndromatic and symptomatic remission, syndromatic persistence, and syndromatic persistence
Syndromatic and Symptomatic Remission (N=13) | Symptomatic Persistence (N=21) | Syndromatic Persistence (N=34) | |||
---|---|---|---|---|---|
N (%) | N (%) | N (%) | Test Statistic | ||
Sex (male) | 10 (77) | 14 (67) | 27 (79) | 0.56 | |
Caucasian | 13 (100) | 20 (95) | 33 (97) | Exact | 1.00 |
Mean±SD | Mean±SD | Mean±SD | |||
Age at baseline[range] | 11.5±3.6[4-16] | 9.2±3.5[4-17] | 9.3±3.4[4-17] | 0.13 | |
Age at follow-up[range] | 16.9±4.2[9-22] | 14.5±3.8[9-23] | 14.4±3.6[7-23] | 0.11 | |
SES | 1.5±1.0 | 2.0±1.0 | 1.8±1.0 | 0.26 |
Characteristics of bipolar disorder
Syndromatic and Symptomatic Remission (N=13) | Symptomatic Persistence (N=21) | Syndromatic Persistence (N=34) | |||
---|---|---|---|---|---|
Median (Q1, Q3) | Median (Q1, Q3) | Median (Q1, Q3) | Test Statistic | ||
Baseline Duration | 3 (1, 7) | 3 (2, 6) | 5 (2, 7) | 0.56 | |
Lifetime duration | 7 (4, 9) | 8 (5, 10) | 10 (7, 14) | 0.01 | |
Mean±SD | Mean±SD | Mean±SD | |||
Baseline # of symptoms | 5.5±1.3 | 5.8±1.1 | 6.3±0.9 | 0.04 | |
Lifetime # of symptoms | 6.1±0.9 | 6.0±1.0 | 6.7±0.7 | 0.008 | |
N (%) | N (%) | N (%) | |||
Baseline ultra-rapid or ultradian cycling | 5 (38) | 5 (24) | 13 (39) | 0.48 | |
Lifetime ultra-rapid or ultradian cycling | 7 (54) | 8 (38) | 22 (65) | 0.17 | |
Severe impairment at baseline | 7 (54) | 14 (67) | 25 (74) | 0.44 |